About Hims Hers Health Inc
Ticker
info
HIMS
Trading on
info
NYSE
ISIN
info
US4330001060
Industry
info
Drug Manufacturers - Specialty & Generic
Sector
info
Healthcare
CEO
info
Andrew Dudum
Headquarters
info
2269 Chestnut Street, San Francisco, CA, United States, 94123
Employees
info
2,442
Website
info
hims.com
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.
Metrics
BasicAdvanced
Market cap
info
$4.75B
P/E ratio
info
40.86
EPS
info
$0.51
Dividend Yield
info
0.00%
Beta
info
2.61
Forward P/E ratio
info
52.36
EBIDTA
info
$176M
Ex dividend date
info
-
Price & volume
Market cap
info
$4.75B
Average daily volume
info
45.2M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
40.86
Forward P/E
info
52.36
PEG ratio
info
2.64
Trailing P/E
info
40.86
Price to sales
info
2.02
Price to book
info
9.28
Earnings
EPS
info
$0.51
EPS estimate (current quarter)
info
$0.04
EPS estimate (next quarter)
info
$0.14
EBITDA
info
$176M
Revenues (TTM)
info
$2.35B
Revenues per share (TTM)
info
$10.44
Technicals
Beta
info
2.61
52-week High
info
$70.43
52-week Low
info
$13.74
50-day moving average
info
$22.49
200-day moving average
info
$40.90
Short ratio
info
2.17
Short %
info
45.18%
Management effectiveness
ROE (TTM)
info
25.23%
ROA (TTM)
info
5.29%
Profit margin
info
5.47%
Gross profit margin
info
$1.73B
Operating margin
info
2.72%
Growth
Quarterly earnings growth (YoY)
info
-17.40%
Quarterly revenue growth (YoY)
info
28.40%
Share stats
Outstanding Shares
info
220M
Float
info
208M
Insiders %
info
6.78%
Institutions %
info
85.78%
Analyst Insights & forecasts
info

39% Buy

46% Hold

15% Sell

Based on information from 13 analysts.

Average price target

info
$24.31
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$0.20
$0.12
66.67%
Q1 • 25Beat
$0.17
$0.15
13.33%
Q2 • 25Beat
$0.06
$0.10
-40.00%
Q3 • 25Missed
$0.08
$0.05
60.00%
Q4 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$599M
$15.8M
2.63%
Q3 • 25
$618M
$20.6M
3.33%
Q4 • 25
3.15%
30.60%
26.62%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$2.23B
$1.65B
73.99%
Q3 • 25
$2.15B
$1.61B
74.90%
Q4 • 25
-3.52%
-2.33%
1.23%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$149M
$-887M
$-39M
$91.4M
Q3 • 25
$64.7M
$3.7M
$-101M
$0.8M
Q4 • 25
-56.49%
-100.41%
158.69%
-99.10%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Hims Hers Health Inc share?
Collapse

Hims Hers Health Inc shares are currently traded for undefined per share.

How many shares does Hims Hers Health Inc have?
Collapse

Hims Hers Health Inc currently has 220M shares.

Does Hims Hers Health Inc pay dividends?
Collapse

No, Hims Hers Health Inc doesn't pay dividends.

What is Hims Hers Health Inc 52 week high?
Collapse

Hims Hers Health Inc 52 week high is $70.43.

What is Hims Hers Health Inc 52 week low?
Collapse

Hims Hers Health Inc 52 week low is $13.74.

What is the 200-day moving average of Hims Hers Health Inc?
Collapse

Hims Hers Health Inc 200-day moving average is $40.90.

Who is Hims Hers Health Inc CEO?
Collapse

The CEO of Hims Hers Health Inc is Andrew Dudum.

How many employees Hims Hers Health Inc has?
Collapse

Hims Hers Health Inc has 2,442 employees.

What is the market cap of Hims Hers Health Inc?
Collapse

The market cap of Hims Hers Health Inc is $4.75B.

What is the P/E of Hims Hers Health Inc?
Collapse

The current P/E of Hims Hers Health Inc is 40.86.

What is the EPS of Hims Hers Health Inc?
Collapse

The EPS of Hims Hers Health Inc is $0.51.

What is the PEG Ratio of Hims Hers Health Inc?
Collapse

The PEG Ratio of Hims Hers Health Inc is 2.64.

What do analysts say about Hims Hers Health Inc?
Collapse

According to the analysts Hims Hers Health Inc is considered a hold.